BSESunil Healthcare LtdMinimalNeutral
Announced Tue, 7 Apr · 16:22 IST

Compliance Certificate u/r 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31st March 2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹61.99
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8+3.2+1.6+3.2+3.2+3.6+0.8-1.5+14.1
Up moveDown movePending
AI summary

Sunil Healthcare Ltd has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ending March 31, 2026. The certificate was issued by the company's Registrar and Transfer Agent (RTA), Alankit Assignments Limited, dated April 4, 2026. It confirms that physical share certificates received for dematerialization of equity shares have been properly processed — the securities were listed on the Stock Exchanges, the physical certificates were verified, mutilated, and cancelled, and the depository has been substituted as the registered owner in the RTA's records. The company secretary Satyendu Pattnaik filed this with BSE and CSE on April 7, 2026.

Likely market impact

This is a routine regulatory compliance filing confirming proper dematerialization procedures were followed. No impact on stock price or shareholder value — it simply verifies that the RTA handled physical-to-dematerialized share conversions correctly as mandated by SEBI.